Predominance of heart failure in the heart of Soweto study cohort: Emerging challenges for urban African communities

Circulation

Volumn 118, Issue 23, 2008, Pages 2360-2367

  Stewart, Simon ^a,c   Wilkinson, David ^a,b   Hansen, Craig ^b   Vaghela, Vinesh ^a   Mvungi, Robert ^a   McMurray, John ^d   Sliwa, Karen ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Africa; Epidemiological transition; Epidemiology; Heart failure; Population

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AFRICA; AGED; ANEMIA; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL SERVICE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; TRICUSPID VALVE REGURGITATION; URBAN POPULATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; COMORBIDITY; FEMALE; HEART DISEASES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URBAN POPULATION;

EID: 58149105364     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.786244     Document Type: Article

References (28)

1. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pierard L, Remme WJESC. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology. Eur Heart J. 2005;26:1115-1140.
2. McMurray JJ, Stewart S. Epidemiology, etiology and prognosis of heart failure. Heart. 2000;83:596-602.
3. Stewart S, MacIntyre K, Capewell S, McMurray JJV. Heart failure and the ageing population: an increasing burden in the 21st century? Heart. 2003;89:49-53.
4. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108:977-982.
5. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for readmission: a systematic review of randomised trials. J Am Coll Cardiol. 2004;44:810-819.
6. Damasceno A, Cotter G, Sliwa K, Mayosi BM. Heart failure in sub-Saharan Africa: time for action. J Am Coll Cardiol. 2007;17: 16988-16993.
7. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007; 93:1176-1183.
8. Cosnett JE. Heart disease in the Zulu: especially cardiomyopathy and cardiac infarction. Br Heart J. 1962;24:76-82.
9. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation. 2005;112:3577-3583.
10. Sliwa K, Wilkinson D, Hansen C, Ntyinyane L, Tibazarwa K, Becker A, Stewart S. A broad spectrum of heart disease and risk factors in a black urban population in South Africa: results from the Heart of Soweto Study Clinical Registry. Lancet. 2008;371:915-922.
11. Stewart S, Wilkinson D, Becker A, Askew D, Ntyintyane, McMurray J, Sliwa K. Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. Int J Cardiol. 2006; 101:101-108.
12. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, Stewart S. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study "Heart Awareness Days." Int J Cardiol. February 1, 2008. doi:10.1016/j.ijcard.2007.11.067. Accessed September 1, 2008.
13. Commerford P, Mayosi BM. An appropriate research agenda for heart research in Africa. Lancet. 2006;367:1884-1886.
14. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston Mass: John Wright: 1982.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A, for the Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
16. Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, on behalf of the EuroHeart Survey Investigators. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27: 2725-2736.
17. Sliwa K, Norton G, Kone N, Candy G, Kachope J, Woodiwiss J, Libhaber C, Sareli P, Essop R. Impact of initiating carvedilol before angiotensin converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J Am Coll Cardiol. 2004;44:1825-30.
18. Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Blackett KN, Nkouonlack DC, Burch VC, Rebe K, Parish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Shey MS, Magula NP, Commerford PJ. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006;6:2.
19. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006; 368:687-693.
20. Davies J. Endomyocardial fibrosis: heart disease of obscure etiology in Africans. E Afr Med J. 1948;25:10-16.
21. Antony KK. Pattern of cardiac failure in Northern Savanna Nigeria. Trop Geogr Med. 1980;32:118-125.
22. Kingue S, Dzudie A, Menanga A, Akono M, Ouankou M, Muna W. A new look at adult chronic heart failure in Africa in the age of the Doppler echocardiography: experience of the medicine department at Yaoundé General Hospital. Ann Cardiol Angeiol (Paris). 2005;54:276-283.
23. Rame JE, Ramilo M, Spencer N, Blewett C, Mehta SK, Dries D, Drazner MH. Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol. 2004;93:234-237.
24. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as a cause of ventricular dilatation in active rheumatic carditis. J Am Coll Cardiol. 1993;22:826-829.
25. Amira C, Ntyintyane L, Wilkinson D, Stewart S, Sliwa K. Emerging epidemic of cardiovascular disease among urban Africa: acute coronary syndrome at Baragwanath Hospital, Soweto. S Afr Heart J. 2006; 3:7-12.
26. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
27. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, on behalf of the BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-750.
28. von Elm E, Altman DG, Eggers M, Pocock S J, Gotzsche PC, Vandenbroucke JP, for the STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull WHO. 2007;85: 867-872.